Ruling Out Acute Coronary Syndromes: Troponin Is Essential, as Is Clinical Assessment

In this issue of the Journal, Nestelberger et al.(6)aimed to validate, in an external large cohort of patients evaluated for suspected ACS in the ED, the performance of the extended algorithm in the prediction of short-term MACE (death, cardiac arrest, AMI [including the index event], cardiogenic sh...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American College of Cardiology Vol. 74; no. 7; pp. 855 - 857
Main Authors Cediel, Germán, Bardají, Alfredo, Barrabés, José A.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 20.08.2019
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0735-1097
1558-3597
1558-3597
DOI10.1016/j.jacc.2019.05.065

Cover

More Information
Summary:In this issue of the Journal, Nestelberger et al.(6)aimed to validate, in an external large cohort of patients evaluated for suspected ACS in the ED, the performance of the extended algorithm in the prediction of short-term MACE (death, cardiac arrest, AMI [including the index event], cardiogenic shock, sustained ventricular arrhythmia, or high-grade atrioventricular block) or MACE + UA (angina with coronary revascularization within 24 h) and compare it with that of the ESC hs-cTn 0/1 h algorithm. Analyses were performed in 3,123 patients from the APACE (Advantageous Predictors of Acute Coronary Syndrome Evaluation) study with no ST-segment elevation, a clear final diagnosis, and two 0/1 hs-cTn determinations available.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-3
ISSN:0735-1097
1558-3597
1558-3597
DOI:10.1016/j.jacc.2019.05.065